Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2002 2
2003 5
2004 12
2005 6
2006 10
2007 8
2008 16
2009 8
2010 8
2011 10
2012 15
2013 12
2014 12
2015 11
2016 15
2017 21
2018 22
2019 13
2020 8
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

185 results
Results by year
Filters applied: . Clear all
Page 1
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.
Wilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, Cornely OA, Rahav G, Bouza E, Lee C, Jenkin G, Jensen W, Kim YS, Yoshida J, Gabryelski L, Pedley A, Eves K, Tipping R, Guris D, Kartsonis N, Dorr MB; MODIFY I and MODIFY II Investigators. Wilcox MH, et al. N Engl J Med. 2017 Jan 26;376(4):305-317. doi: 10.1056/NEJMoa1602615. N Engl J Med. 2017. PMID: 28121498 Free article. Clinical Trial.
Implementation of a national bundle care program to reduce catheter-associated urinary tract infection in high-risk units of hospitals in Taiwan.
Lai CC, Lee CM, Chiang HT, Hung CT, Chen YC, Su LH, Shi ZY, Liu JW, Liu CP, Lu MC, Chuang YC, Ko WC, Tseng SH, Chen YH, Hsueh PR; Infection Control Society of Taiwan. Lai CC, et al. Among authors: chuang yc. J Microbiol Immunol Infect. 2017 Aug;50(4):464-470. doi: 10.1016/j.jmii.2017.01.006. Epub 2017 Jun 26. J Microbiol Immunol Infect. 2017. PMID: 28711430 Free article.
Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial.
Yuan J, Mo B, Ma Z, Lv Y, Cheng SL, Yang Y, Tong Z, Wu R, Sun S, Cao Z, Wu J, Zhu D, Chang L, Zhang Y; Investigator Group of the Phase 3 Study on Oral Nemonoxacin. Yuan J, et al. J Microbiol Immunol Infect. 2019 Feb;52(1):35-44. doi: 10.1016/j.jmii.2017.07.011. Epub 2017 Aug 2. J Microbiol Immunol Infect. 2019. PMID: 30181096 Free article. Clinical Trial.
Vibrio vulnificus in Taiwan.
Hsueh PR, Lin CY, Tang HJ, Lee HC, Liu JW, Liu YC, Chuang YC. Hsueh PR, et al. Among authors: chuang yc. Emerg Infect Dis. 2004 Aug;10(8):1363-8. doi: 10.3201/eid1008.040047. Emerg Infect Dis. 2004. PMID: 15496235 Free PMC article. Review.
Antimicrobial stewardship for acute-care hospitals: An Asian perspective.
Apisarnthanarak A, Kwa AL, Chiu CH, Kumar S, Thu LTA, Tan BH, Zong Z, Chuang YC, Karuniawati A, Tayzon MF, So TM, Peterson LR. Apisarnthanarak A, et al. Among authors: chuang yc. Infect Control Hosp Epidemiol. 2018 Oct;39(10):1237-1245. doi: 10.1017/ice.2018.188. Epub 2018 Sep 19. Infect Control Hosp Epidemiol. 2018. PMID: 30227898 Review.
Combating antimicrobial resistance: antimicrobial stewardship program in Taiwan.
Tseng SH, Lee CM, Lin TY, Chang SC, Chuang YC, Yen MY, Hwang KP, Leu HS, Yen CC, Chang FY. Tseng SH, et al. Among authors: chuang yc. J Microbiol Immunol Infect. 2012 Apr;45(2):79-89. doi: 10.1016/j.jmii.2012.03.007. Epub 2012 Apr 5. J Microbiol Immunol Infect. 2012. PMID: 22483434 Free article. Review.
2016 guidelines for the use of antifungal agents in patients with invasive fungal diseases in Taiwan.
Kung HC, Huang PY, Chen WT, Ko BS, Chen YC, Chang SC, Chuang YC; Infectious Diseases Society of Taiwan; Medical Foundation in Memory of Dr. Deh-Lin Cheng; Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research and Education; CY Lee's Research Foundation for Pediatric Infectious Diseases and Vaccines. Kung HC, et al. Among authors: chuang yc. J Microbiol Immunol Infect. 2018 Feb;51(1):1-17. doi: 10.1016/j.jmii.2017.07.006. Epub 2017 Jul 25. J Microbiol Immunol Infect. 2018. PMID: 28781150 Free article. Review.
185 results